P

Inventor

TAJIMI MASAOMI

JP14 patents
⚠️ This page may combine multiple inventors who share the name “TAJIMI MASAOMI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

XENTION LTD

4 patents
US7615557B2Nov 10, 2009

Tetrahydro-naphthalene and urea derivatives

XENTION LTD9 citations81
US7381840B2Jun 3, 2008

Tetrahydro-naphthalene derivatives

XENTION LTD7 citations72
US7612113B2Nov 3, 2009

Hydroxy tetrahydro-naphthalenylurea derivatives

XENTION LTD6 citations61
US7544716B2Jun 9, 2009

Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists

XENTION LTD6 citations61

BAYER HEALTHCARE AG

2 patents
US7423175B2Sep 9, 2008

Hydroxy-tetrahydro-naphthalenylurea derivatives

BAYER HEALTHCARE AG4 citations62
US7064229B2Jun 20, 2006

Succinic acid derivatives

BAYER HEALTHCARE AG0 citations36

TAJIMI MASAOMI

2 patents
US8173841B2May 8, 2012

Tetrahydro-naphthalene derivatives

TAJIMI MASAOMI1 citations47
US8088826B2Jan 3, 2012

Tetrahydro-naphthalene derivatives

TAJIMI MASAOMI0 citations47

BAYER AG

2 patents
US7091242B2Aug 15, 2006

Beta-amino acid derivatives as integrin receptor antagonists

BAYER AG0 citations38
US6794386B2Sep 21, 2004

β-amino acid compounds as integrin antagonists

BAYER AG0 citations37

HK INNO N CORP

1 patent
US11033532B2Jun 15, 2021

Uses of benzimidazole derivative for nocturnal acid breakthrough

HK INNO N CORP0 citations57

CJ HEALTHCARE CORP

1 patent
US10512635B2Dec 24, 2019

Uses of benzimidazole derivative for nocturnal acid breakthrough

CJ HEALTHCARE CORP1 citations57

SHIMADA KAORU

1 patent
US10975070B2Apr 13, 2021

Ghrelin receptor agonist for treatment of cachexia

SHIMADA KAORU0 citations54

BAYER SCHERING PHARMA AG

1 patent
US7683076B2Mar 23, 2010

Tetrahydro-quinolinylurea derivatives

BAYER SCHERING PHARMA AG0 citations38